Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2-(diethylamino)-1-methylethyl Cis-1- Hydroxy(bicyclohexyl)-2-carboxylate
2. Rilaten
1. Schembl1649735
2. Q3939643
| Molecular Weight | 339.5 g/mol |
|---|---|
| Molecular Formula | C20H37NO3 |
| XLogP3 | 4.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 339.27734404 g/mol |
| Monoisotopic Mass | 339.27734404 g/mol |
| Topological Polar Surface Area | 49.8 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 390 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AA - Synthetic anticholinergics, esters with tertiary amino group
A03AA06 - Rociverine
Global Sales Information
Market Place
ABOUT THIS PAGE
60
PharmaCompass offers a list of Rociverine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rociverine manufacturer or Rociverine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rociverine manufacturer or Rociverine supplier.
PharmaCompass also assists you with knowing the Rociverine API Price utilized in the formulation of products. Rociverine API Price is not always fixed or binding as the Rociverine Price is obtained through a variety of data sources. The Rociverine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rilaten manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rilaten, including repackagers and relabelers. The FDA regulates Rilaten manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rilaten API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rilaten supplier is an individual or a company that provides Rilaten active pharmaceutical ingredient (API) or Rilaten finished formulations upon request. The Rilaten suppliers may include Rilaten API manufacturers, exporters, distributors and traders.
Rilaten Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rilaten GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rilaten GMP manufacturer or Rilaten GMP API supplier for your needs.
A Rilaten CoA (Certificate of Analysis) is a formal document that attests to Rilaten's compliance with Rilaten specifications and serves as a tool for batch-level quality control.
Rilaten CoA mostly includes findings from lab analyses of a specific batch. For each Rilaten CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rilaten may be tested according to a variety of international standards, such as European Pharmacopoeia (Rilaten EP), Rilaten JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rilaten USP).
